Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Despite China Weakness, Lilly Gung-Ho On Forteo, Humalog

This article was originally published in PharmAsia News

Executive Summary

Eli Lilly said in its Q4 earning call that slowdown in emerging markets would continue in the coming year, highlighting a tough year in China, with possible worse growth in the country depending on its on-going whole pricing policies. Though some brands will remain strong and accelerate growth, particularly Forteo.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register